{"title":"Transient Osteoporosis of the Hip: A Differential Diagnosis which is Not to Be Missed","authors":"M. Joshi, Punit Nauwal, N. Prakash","doi":"10.3109/10582452.2014.933995","DOIUrl":"https://doi.org/10.3109/10582452.2014.933995","url":null,"abstract":"Abstract Background: Transient osteoporosis of the hip [TOH] is a rare clinical syndrome with an unknown pathogenesis. Clinical history and radiological investigations establish the diagnosis. Conservative management is the mainstay of treatment. Presented here is the conservative management of two cases of men with TOH. Findings: Magnetic resonance imaging and bone scan showed changes consistent with TOH, which resolved after initiation of treatment. Conclusion: Transient osteoporosis of the hip needs to be considered in the differential diagnosis of hip joint pain in middle-aged men with a functional disability. Prompt initial clinical evaluation with vigilant monitoring and follow-ups are a must to identify and treat complications.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"22 1","pages":"392 - 395"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.933995","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Bertin, F. Rannou, L. Grange, Jean-Noel Dachicourt, P. Bruel, C. Emery, N. Grandfils, C. Taieb
{"title":"Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France","authors":"P. Bertin, F. Rannou, L. Grange, Jean-Noel Dachicourt, P. Bruel, C. Emery, N. Grandfils, C. Taieb","doi":"10.3109/10582452.2014.937550","DOIUrl":"https://doi.org/10.3109/10582452.2014.937550","url":null,"abstract":"ABSTRACT Objectives: The economic burden of osteoarthritis [OA] has not recently been evaluated in France. This study aimed to provide a health economic update of the patient costs associated with hip or knee OA treated in the community and in medical, surgical and obstetric care [MSO] and post-acute care and rehabilitation [PAC] hospitals in France. Methods: We analyzed data from the Disease Analyzer® database of medical records collected by a representative sample of French general practitioners in 2009–2010 and from the French medical information system program for public and private hospitals in 2010. Results: In 2010, 90 946 patients were hospitalized in MSOs for hip OA [median age: 75 years] and 84 848 patients for knee OA [median age: 71 years], of whom 44% and 61%, respectively, were transferred to PACs. Up to 94.5% of patients underwent joint replacement. Hospitalization engendered annual costs of €9797 per patient with hip OA and €11 644 per patient with knee OA, that is, a total cost of €1.955 billion for patients hospitalized for hip or knee OA in 2010. A total of 18 976 community patients [mean age: 66 ± 12.7 years] with OA were followed up for 1 year in the Disease Analyzer® database. The annual costs per patient were €715 and €764 for hip and knee OA, respectively, including a cost to the healthcare system of €425 and €454, respectively, that is, an estimated €3.5 billion [€2 billion to the healthcare system] for 4.6 million patients. Conclusion: Patients with OA generate considerable healthcare costs in France.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"22 1","pages":"356 - 364"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.937550","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cognitive Coping Predicts Pain Intensity and Disability in Patients with Upper Extremity Musculoskeletal Pain","authors":"A. Vranceanu, D. Ring","doi":"10.3109/10582452.2014.976326","DOIUrl":"https://doi.org/10.3109/10582452.2014.976326","url":null,"abstract":"Abstract Objective: The Negative Pain Thoughts Questionnaire [NPTQ], Pain Catastrophizing Scale [PCS], and Pain Self-Efficacy Questionnaire [PSEQ] are validated measures of cognitive coping with pain. The objective of this study was to assess their individual and combined interrelation with pain intensity and disability, and determine the amount of overlap variance among these coping measures. Methods: One hundred and nineteen patients presenting to a hand practice completed validated questionnaires assessing pain intensity [an 11-point ordinal scale], and disability [the Disabilities of the Arm, Shoulder and Hand Questionnaire; DASH] along with the three cognitive coping questionnaires. Results: Regression models with NPTQ controlling for covariates explained 24% of variance in pain intensity, of which NPTQ alone explained 10%, and 32% in DASH, of which NPTQ alone explained 16%. Regression models with PCS controlling for covariates explained 24% of variance in pain intensity, of which PCS alone explained 10% and 46% in DASH, of which PCS alone explained 29%. Regression models with PSEQ controlling for covariates explained 29% of variance in pain intensity, of which PSEQ alone explained 16% and 56% in DASH, of which PSEQ alone explained 39%. Models including all variables explained 31% of the variance in pain intensity and 61% of the variance in DASH. Pain self-efficacy alone accounted for five percent of the variance in pain intensity and 14% of the variance in DASH scores. The three cognitive coping measures shared a large amount of overlapping variance. Conclusion: Pain self-efficacy may be most useful for understanding variations in arm pain and disability.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"22 1","pages":"373 - 377"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.976326","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jae-Wook Jung, Seong Rok Kim, S. Jeon, S. Bang, Y. H. Kim, Sang Eun Lee
{"title":"Cardiac Tamponade Following Ultrasonography-Guided Trigger Point Injection","authors":"Jae-Wook Jung, Seong Rok Kim, S. Jeon, S. Bang, Y. H. Kim, Sang Eun Lee","doi":"10.3109/10582452.2014.907850","DOIUrl":"https://doi.org/10.3109/10582452.2014.907850","url":null,"abstract":"Abstract Background: Trigger point injection [TPI] is generally considered a safe and easy procedure. Findings: We describe a case of cardiac tamponade after ultrasonography [US]-guided TPI in a thin patient. The symptoms progressively appeared directly after the injection, and the patient experienced cardiogenic shock 3 h later. Cardiac tamponade was diagnosed with difficulty when US was performed near the injection site, and then pericardiocentesis was performed immediately. Conclusions: When US-guided TPI is performed near the neck and chest, the authors suggest that the entire shaft and tip of the needle be identified to prevent any critical complications during an US-guided procedure.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"22 1","pages":"389 - 391"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.907850","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"New Aspects on Chronic Trapezius Myalgia: Contribution of Metabolomics and Proteomics","authors":"J. Hadrévi","doi":"10.3109/10582452.2014.949335","DOIUrl":"https://doi.org/10.3109/10582452.2014.949335","url":null,"abstract":"Abstract Several hypotheses regarding the underlying mechanisms and the maintenance behind chronic work-related musculoskeletal disorders have been presented. Chronic low load work and psychosocial stress is believed to be the underlying causes to these pain conditions. The recent application of comprehensive screening methods: omnics methods; to this field of research could contribute to current knowledge regarding the pathophysiology of these disorders. The pathophysiological mechanisms behind chronic trapezius myalgia are discussed in the context of new findings obtained with proteomic and metabolomic methods. Proteins and metabolites which differ in abundance between healthy muscle and muscle suffering from chronic trapezius myalgia are presented. Primarily, the pathways and effects of the proteins and metabolites found in three recently published papers are discussed. Proteomics and metabolomics are efficient screening methods enabling the presentation of potential biomarkers and pathophysiological mechanisms explaining the pathophysiology of chronic work-related trapezius myalgia. The previous findings detecting systematic differences of proteins and metabolites when comparing chronic myalgic muscle to healthy muscle, indicating a higher glycogen metabolism, increased muscle turnover and increased neuronal signalling in the myalgic muscle, are discussed in this review.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"19 1","pages":"382 - 388"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.949335","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Musculoskeletal Pain as Related to Some Diet Items and Fatty Acids in the Cross-Sectional Oslo Health Study","authors":"A. Høstmark, A. Haug, G. Holmboe-Ottesen","doi":"10.3109/10582452.2014.951818","DOIUrl":"https://doi.org/10.3109/10582452.2014.951818","url":null,"abstract":"Abstract Objectives: Antioxidants and a balanced ratio between Omega-3 and Omega-6 fatty acids may influence musculoskeletal pain, raising the question of whether pain is related to intake of particular food items. Methods: In the cross-sectional Oslo Health Study, including 18 770 men and women, there were 12 025 subjects with data on musculoskeletal pain, and on intake of various food items. We calculated the Sumpain index to estimate the extent/severity of pain. Using multiple linear regression models, we studied the association between Sumpain and diet items possibly related to pain. In addition, the Omega-3/Omega-6 fatty acid ratio in serum phospholipids was determined in 139 of the subjects; 84 ethnic Norwegians and 55 Pakistani immigrants. Results: Sumpain was negatively associated with intake of fruits/berries and fruit juice, when controlling for sex, age, smoking, body mass index, length of education, physical activity, and intake of coffee, alcohol, fruit juice, vegetables/salads, fatty fish, and cod liver oil. Sumpain was higher in women than in men, and was negatively associated with intake of alcohol, length of education and physical activity, but was positively related to age, body mass index and smoking. The Omega-3/Omega-6 fatty acid ratio in serum phospholipids was negatively associated with Sumpain, and was lower in the immigrant group, which had a higher mean Sumpain score. Conclusions: The results raise the question of whether intake of fruits/berries, fruit juice, and a balanced fatty acid pattern in serum phospholipids, might protect against musculoskeletal pain.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"117 1","pages":"365 - 372"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.951818","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicole M. Protzman, Christine Pfisterer, A. Malhotra, Jason E Kooch
{"title":"Peripheral Nerve Field Stimulation: Feasibility of Subcutaneous Placement under Ultrasound Guidance","authors":"Nicole M. Protzman, Christine Pfisterer, A. Malhotra, Jason E Kooch","doi":"10.3109/10582452.2014.933996","DOIUrl":"https://doi.org/10.3109/10582452.2014.933996","url":null,"abstract":"Abstract Background: Although peripheral nerve field stimulation [PNFS] does not have one precise target, accurate placement within the subdermal space is critical for optimal results. Findings: In the present report, a 71-year-old female underwent a PNFS trial. Under ultrasound guidance, the physician placed two leads. Following the trial, the patient reported clinically significant improvements in pain and function. Conclusions: Ultrasound guidance provided delineation between the subcutaneous and muscular layers, which afforded visualization of lead depth. However, future prospective cohort studies and randomized controlled trials are needed to definitely evaluate the use of ultrasound guidance for lead placement.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"22 1","pages":"396 - 399"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.933996","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chien-Min Chen, H. Hsu, W. Tsai, Chia-Hao Chang, Chu-Hsu Lin, Kai-Hua Chen, Yi-Hsuan Lai
{"title":"The “Bodily Pain” Scale of the Short Form-36 Questionnaire is a Predictor of Outcome in Patients who Receive Ultrasound-Guided Corticosteroid Injection for Plantar Fasciitis—A Preliminary Study","authors":"Chien-Min Chen, H. Hsu, W. Tsai, Chia-Hao Chang, Chu-Hsu Lin, Kai-Hua Chen, Yi-Hsuan Lai","doi":"10.3109/10582452.2014.907854","DOIUrl":"https://doi.org/10.3109/10582452.2014.907854","url":null,"abstract":"Abstract Objectives: Ultrasound-guided corticosteroid injection is an effective treatment for plantar fasciitis. We aimed to examine whether the eight scales of the Short Form-36 [SF-36] quality of life questionnaire could predict outcome of ultrasound-guided corticosteroid injection for plantar fasciitis. Methods: Sixteen patients [mean age 55.7 years] with unilateral plantar fasciitis received ultrasound-guided corticosteroid injections and all evaluations. The SF-36 questionnaire was administered and tenderness threshold [TT] was measured before injection, at 3 weeks, and at 3 months post-injection. Differences in the eight SF-36 scales among the three time points were examined. Furthermore, baseline measurements and changes in the SF-36 scales were examined for their association with changes in TT at 3 weeks and 3 months post-injection. Results: The scale “bodily pain” [BP] decreased significantly after injection [baseline versus 3 months post-injection: 46.25 ± 11.73 versus 63.06 ± 18.26; p = 0.036]. Baseline BP correlated with change in TT at 3 weeks [r = −0.554, p = 0.026]. The change in BP correlated with change in TT at 3 weeks [r = 0.594, p = 0.015] and at 3 months [r = 0.536, p = 0.032]. Conclusion: The BP scale can be used to predict the outcome of ultrasound-guided corticosteroid injection for plantar fasciitis. Less initial bodily pain leads to less improvement in objective inferior heel tenderness.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"22 1","pages":"335 - 340"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.907854","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Multi-Modal Pain Therapy of Fibromyalgia Syndrome with Integration of Systemic Whole-Body Hyperthermia – Effects on Pain Intensity and Mental State: A Non-Randomised Controlled Study","authors":"Tobias Romeyke, H. Stummer","doi":"10.3109/10582452.2014.949336","DOIUrl":"https://doi.org/10.3109/10582452.2014.949336","url":null,"abstract":"Abstract Objectives: This controlled study evaluates a multi-modal pain therapy for treating severe progressions of fibromyalgia [FMS] syndrome. The aim is to establish whether the use of multi-modal therapy with inclusion of whole-body hyperthermia represents a useful therapeutic addition to inpatient therapy of FMS syndrome at a high level of chronification. Methods: The study involved 130 patients who fulfilled the criteria of the American College of Rheumatology [ACR] for FMS and whose disease showed severe progression. One group of patients [HTG] received whole-body hyperthermia, while the control group [CG] did not. The main parameters of the study were pain intensity and the mental state of the patients. Further study parameters were the diagnoses additional to FMS syndrome and the therapy density of the treatment provided in the two groups. Results: The integration of whole-body hyperthermia into the multi-modal pain therapy showed superior pain reduction [p = 0.023] and an improvement in the mental state of the patients [p = 0.055]. In addition to the primary disease, the patients presented with an average of 6.7 accompanying diseases, primarily from major diagnostic categories 8 [diseases and disturbances of the musculoskeletal system and connective tissues], 19 [mental diseases and disturbances] and 10 [endocrine, nutritional and metabolic diseases]. Analysis of the therapy density of the inpatient multi-modal pain therapy revealed a close-meshed and high-frequency therapy. Conclusions: Multi-modal pain therapy was also found to be a highly effective therapy option in the case of severely progressive FMS syndrome. Extension of the multi-modal therapy setting to include whole-body hyperthermia can be considered as a useful and effective complement for pain relief and stabilisation of the mental state.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"22 1","pages":"341 - 355"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.949336","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Shilo, R. Hadari, A. Shabun, D. Shilo, Y. Kitay-Cohen
{"title":"Xiphodynia: An Easily Diagnosed but Frequently Overlooked Cause of Non-cardiac Chest Pain","authors":"L. Shilo, R. Hadari, A. Shabun, D. Shilo, Y. Kitay-Cohen","doi":"10.3109/10582452.2014.962212","DOIUrl":"https://doi.org/10.3109/10582452.2014.962212","url":null,"abstract":"Abstract Background: Various syndromes of chest pain caused by gastro-esophageal reflux disease, inflammation or trauma to the chest wall structures have been described. These syndromes should be differentiated from serious disorders such as myocardial ischemia, pulmonary embolism, aortic dissection and pancreatitis. Only few case reports exist that describe pain in the xyphoid region (i.e. xiphodynia) that mimicked serious causes of chest pain, and lead to unnecessary, costly and sometimes invasive evaluations. Objectives: To describe a cohort of adult patients suffering from xiphodynia. Additionally, we reviewed the patient's charts for unnecessary diagnostic procedures and relate to the diagnosis and treatment of xiphodynia. Methods: An 18-month observational study of patients suffering from pain in the xyphoid region was conducted in a 40-bed medical ward at a tertiary care university hospital. Patient's charts were reviewed for evaluation, diagnostic procedures and treatment. Results: Out of 428 patients discharged with the diagnosis of non-cardiac chest pain during this period, 14 patients suffering from xiphodynia were identified. Prior to diagnosis nine patients underwent various diagnostic procedures, including cardiac catheterization. After diagnosis, eight patients were treated by injection of a combination of long-acting steroid combined with local anesthetic to the xyphoid region with achievement of immediate and long lasting relief of the pain in most cases. We stress the observation that xiphodynia is under-recognized in general practice, an observation that leads to increased patient morbidity and medical costs.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"55 1","pages":"378 - 381"},"PeriodicalIF":0.0,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2014.962212","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69500740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}